Wisconsin Health Press: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Wisconsin Health Press.

Press releases published on October 5, 2026

Ostia Sciences Publishes Second International Patent Application Covering the Sorbitol Switch That Drives Production of Phosphorylated Lantibiotics
Medicovestor Announces FDA IND Clearance for MC001, Advancing to An International Phase 1 Study
Assembly Biosciences to Present Positive Phase 1a Safety, Tolerability and Target Engagement Data for ABI-6250 at AASLD The Liver Meeting® 2026
Alpha Tau to Participate in October Investor Conferences
AFTD Welcomes the International Society for Frontotemporal Dementias to Philadelphia
AIM ImmunoTech Highlights Recent Media Coverage of Ampligen’s® Broad-Spectrum Antiviral and Biodefense Potential
Freya Biosciences named as one of Fierce Biotech’s “Fierce 15” for 2026
Kymanox Launches KymaBridge, an Intelligence Platform Connecting Pharma and Biotech Innovators with Drug Delivery Device Technologies
Beacon Therapeutics Named a “Fierce 15” Company by Fierce Biotech
Curia Invests $28 Million in Sterile API Manufacturing
Curia investiert 28 Mio. USD in die Herstellung steriler Wirkstoffe
Curia invierte $28 millones en la fabricación de API estériles
Curia investit 28 millions de dollars dans la fabrication d’API stériles
קוריה משקיעה 28 מיליון דולר בייצור רכיבים פעילים (API) סטריליים
Curia Berinvestasi $28 Juta untuk Manufaktur API Steril
キュリア、無菌API製造に2800万ドル (約44億円) を投資
Curia, 무균 API 생산에 2,800만 달러 투자
Curia Melabur AS$28 Juta dalam Pengeluaran API Steril
Curia Investe US$ 28 Milhões na Fabricação de IFAs Estéreis
Curia ลงทุน 28 ล้านดอลลาร์สหรัฐฯ ในการผลิตสารออกฤทธิ์ทางเภสัชกรรม (Active Pharmaceutical Ingredient: API) ปลอดเชื้อ

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Wisconsin Health Press

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.